𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liver resection for colorectal cancer metastases involving the caudate lobe

✍ Scribed by R. L. Thomas; J. T. Lordan; K. Devalia; N. Quiney; W. Fawcett; T. R. Worthington; N. D. Karanjia


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
124 KB
Volume
98
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Up to 5 per cent of liver resections for colorectal cancer metastases involve the caudate lobe, with cancer-involved resection margins of over 50 per cent being reported following caudate lobe resection.

Methods

Outcomes of consecutive liver resections for colorectal metastases involving the caudate lobe between 1996 and 2009 were reviewed retrospectively, and compared with those after liver surgery without caudate resection.

Results

Twenty-five patients underwent caudate and 432 non-caudate liver resection. Caudate resection was commonly performed as part of extended resection. There were no differences in operative complications (24 versus 21Β·1 per cent; P = 0Β·727) or blood loss (median 300 versus 250 ml; P = 0Β·234). The operating time was longer for caudate resection (median 283 versus 227 min; P = 0Β·024). Tumour size was larger in the caudate group (median 40 versus 27 mm; P = 0Β·018). Resection margins were smaller when the caudate lobe was involved by tumour, than in resections including tumour-free caudate or non-caudate resection; however, there was no difference in the proportion of completely excised tumours between caudate and non-caudate resections (96 versus 96Β·1 per cent; P = 0Β·990). One-year overall survival rates were 90 and 89Β·3 per cent respectively (P = 0Β·960), with 1-year recurrence-free survival rates of 62 and 71Β·2 per cent (P = 0Β·340).

Conclusion

Caudate lobe surgery for colorectal cancer liver metastases does not increase the incidence of resection margin involvement, although when the caudate lobe contains metastases the margins are significantly closer than in other resections.


πŸ“œ SIMILAR VOLUMES


Metastatic inefficiency: The scientific
✍ Dr. Paul H. Sugarbaker πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

Hematogenous metastases from primary colon or rectal cancer develop in a definite step-wise fashion. In most patients the primary tumor disseminates to local lymph nodes, to the liver, or to peritoneal surfaces. Lung metastases only develop after considerable progression of the secondary tumor depos

Chemotherapy for colorectal cancer prior
✍ Ajay Sahajpal; Charles M. Vollmer Jr.; Elijah Dixon; Elisa K. Chan; Alice Wei; M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

## Abstract ## Background Systemic chemotherapy is being used increasingly in patients with colorectal cancer. The effects of prior systemic adjuvant or palliative chemotherapy on morbidity following hepatic resection for metastases are not well defined. ## Objectives To assess the peri‐operativ

Liver fatty acid-binding protein is a ne
✍ Yamazaki, Toshiyuki; Kanda, Tatsuo; Sakai, Yasuo; Hatakeyama, Katsuyoshi πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 280 KB πŸ‘ 2 views

Background and Objectives: Liver fatty acid-binding protein (L-FABP) is reported as a biological marker for enterocytic differentiation. We evaluated the prognostic value of L-FABP expression for patients undergoing hepatic resection of colorectal cancer metastases. Methods: The study group comprise

Prognostic index for the development of
✍ Professor I. Taylor; M. A. Mullee; M. J. Campbell πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 280 KB πŸ‘ 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m